Georgia CTSA Newsletter
|
Trouble viewing this email? View on the web.
| |
|  | 
Georgia CTSA
Weekly eRoundup
March 20, 2020
|
| |
| | | | | "In a situation like this where everything is so new, scientific communication and the ability to interpret it becomes a critical issue. We're talking about something that people, up until three months ago, have never dealt with," says Dr. Jeffrey Collins.
Jeffrey Collins, MD, MSc, Assistant Professor, and Russell Kempker, MD, MSc, Associate Professor, Emory University School of Medicine, Division of Infectious Diseases, NIH-funded physician-scientists, ... | | | | Read More | | |
|
| |
| | | | | | The Emory-Georgia Tech Healthcare Innovation Program in partnership with Emory Synergy Award Program, Georgia CTSA, Emory Healthcare Innovation Hub, Emory Health Services Research Center, Winship, Emory+Children's Pediatrics Institute, and Georgia Tech is pleased to announce the fourteenth round of research seed grants in Healthcare Innovation. The funding priority will be for proposals that address issues in dealing with pandemics. | | | | Read More | | |
|
| |
| | | | Georgia CTSA is now offering Virtual Studios to meet your research brainstorming needs. Our on-site presence has temporarily changed, but our desire to help you plan and collaborate regarding existing and potential research has not paused. Examples of areas where we have served past customers with expert brainstorming include locating collaborators and resources, hypothesis generation, study design, implementation, analysis and interpretation, translation and manuscript development of research topics. Contact the Georgia CTSA Coordinating Center by emailing Karen Lindsley at klindsl@emory.edu or Submit a Request for a Studio Consultation. | | | | Submit a Request | | |
| |
| | | | Due to the potential exceptional impact of the declared public health emergency, we want to assure our recipient community that NIH will be doing our part to help you continue your research. Our website on “Coronavirus Disease 2019 (COVID-19): Information for NIH Applicants and Recipients” has a list of available resources. Also, see a video message from Dr. Mike Lauer discussing the flexibilities available for applicants and recipients. | | | | Read More | | |
| |
| | | | For details on expanded flexibilities, such as mid-project period extensions and administrative supplements for unanticipated costs, see NOT-OD-20-087. | | | | Read More | | |
| |
| | | | When delays occur because the applicant or recipient organization is officially closed or unable to submit grant applications due to the effects of COVID-19, the NIH will consider accepting applications late, on a case-by-case basis. See the Guidance Notes. | | | | Read More | | |
| |
| | | | For flexibilities provided in the Public Health Service (PHS) Policy on Humane Care and Use of Laboratory Animals (Policy) that are applicable to implementing a pandemic plan for animal care and use programs, see NOT-OD-20-088. | | | | Read More | | |
| |
| | | | As many as two awards of up to $20,000 each in total direct costs are available to support novel methodological research in biostatistics, epidemiology, or health economics to advance clinical and translational research. New investigators are encouraged to apply; meritorious applications from new investigators will be prioritized for funding. | | | | Read More | | |
| |
| | | | A key innovation strategy is to promote interdisciplinary and cross-departmental and -divisional research. The SOM I3 Education Awards are soliciting proposals that highlight, promote, and disseminate innovations in medical education and training (degree programs and GME) that enhance the Emory SOM mission. | | | | Read More | | |
| |
| | | | A key innovation strategy is to promote interdisciplinary and cross-departmental and -divisional research. The SOM I3 Venture Awards are soliciting proposals to catalyze promising early-stage concepts with commercial potential that do not yet qualify for funding from external sources. | | | | Read More | | |
| |
| | | | Due to the recent outbreak caused by SARS-CoV-2, CCIV is conducting a special call for applications related to SARS-CoV-2 and COVID-19 ONLY. Projects selected for award under this special RFA will have a project period of May 1, 2020 - April 30, 2021. | | | | Read More | | |
| |
| | | | Georgia CTSA's Informatics program is soliciting proposals to support investigator-led teams in developing and testing innovative healthcare apps. The support is for project costs that are associated with data access, informatics resource access, and technical personnel. We strongly encourage applications that use our Real Time Analytics platform. Applications that do not include budget lines for informatics resources will be considered non-responsive. | | | | Read More | | |
| |
| | | | Pfizer Global Medical Grants (GMG) supports the global healthcare community's independent initiatives (e.g., research, quality improvement, or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer's medical and/or scientific strategies. Projects that will be considered for Pfizer support will focus on increasing the understanding of targeted therapies including BRAF inhibitors and their use in the treatment of colorectal cancer (CRC). | | | | Read More | | |
| |
| | | | This RFP is intended to support quality improvement (QI) initiatives that focus on the implementation of updated pneumococcal immunization recommendations, as described in the updated recommendations of the Advisory Committee on Immunization Practices (ACIP) for adult pneumococcal immunization. | | | | Read More | | |
| |
| | | | The funding priority for the seed grants from the Emory-Georgia Tech Healthcare Innovation Program will be for proposals that address issues in dealing with pandemics such as (but not limited to): coordination of public health and healthcare systems in clinical responses, diagnostic testing, provider-patient safety; improving clinical preparedness and communication; impact on healthcare system physicians, nurses, staff. | | | | Read More | | |
| |
| | | | In light of the current COVID-19 outbreak, the dean of the Emory School of Medicine (SOM) has created a special grant cycle of the Dean’s Imagine, Innovate, and Impact (I3) Awards. This I3 Rapid RFP will specifically support the creation of data in preparation for anticipated external funding opportunities related to COVID-19. | | | | Read More | | |
| |
| | | | Pfizer Global Medical Grants (GMG) supports the global healthcare community's independent initiatives (e.g., research, quality improvement, or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer's medical and/or scientific strategies. Projects that will be considered for Pfizer support will focus on increasing the understanding of MAPK pathway inhibitors and their use in the treatment of melanoma. | | | | Read More | | |
| |
| | | | To assist investigators who have temporarily lost significant federal research funding, and to facilitate carefully planned changes in research direction, the Emory School of Medicine offers a Bridge Funding Program. Bridge funding up to $100,000 (including Department support/matching funds) will be available to investigators based on merit, potential for renewal of external funding, and availability of SOM funds. | | | | Read More | | |
| |
| | | | Wake Forest Primate Signature Program provides access to nonhuman primates (NHPs) and related resources for studies that advance translational research. To assist new NHP researchers, the Program is providing funds for feasibility studies to be conducted using monkey-related resources. The objective is to facilitate the collection of data from NHPs in support of applications for extramural funding. Applications are open to faculty members or KL2 scholars of CTSA supported institutions. | | | | Read More | | |
| |
| | | | The purpose of this Notice of Special Interest is to highlight the list of widely appreciated systematic barriers or translational science problems included in PAR-19-099 and PAR-19-100 to add the following topics of interest: Rural Health, Racial and Ethnic Disparities in Maternal Mortality, Applications for Machine Learning and Artificial Intelligence (AI), Veterans' Health. | | | | Read More | | |
| |
| | | | The Emory Master of Science in Clinical Research (MSCR) degree program, in the Laney Graduate School at Emory University, provides innovative didactic and mentored research training to those interested in pursuing a career in clinical and/or translational research. | | | | Read More | | |
| |
| | | | The Certificate Program in Translational Research (CPTR) is a formal 16-credit Emory Laney Graduate School program for trainees who seek to conduct research at the interface between basic and translational science and clinical medicine. | | | | Read More | | |
| |
| | | | The Medical Innovation Residency Track is a 24-month program now open to both Emory and MSM participants to provide a foundation of knowledge to participate in entrepreneurship and design for innovate technologies. Upon successful participation and completion of this track, residents will be awarded a certificate of distinction in Medical Innovation from Emory University School of Medicine. | | | | Read More | | |
| |
| | | | Phlebotomy 101 is a two-day classroom and clinical, hands-on training to venipuncture offered through the Georgia CTSA Clinical Research Centers (GCRCs). The course is offered quarterly to research coordinators from Emory, Morehouse School of Medicine and UGA. | | | | Class Schedule | | |
| |
| | | | The new Georgia CTSA Grant Wise service offers the opportunity for one-on-one feedback from experienced senior faculty on grant writing. We are soliciting experienced faculty to serve as volunteer mentors. If you have experience in writing grants and you enjoy mentoring, we need you! After completing the online volunteer form, we will be in touch should we receive a request that matches your expertise. Contact lauren.james@emory.edu | | | | Volunteer Form | | |
| |
| | | | The Georgia CTSA has partnered with ACT Network to bring real-time cohort exploration and discovery to its researchers. ACT uses a web interface in a HIPAA-compliant manner, without require study-specific IRB approval. It offers open access to a national network of academic medical research centers and generates aggregate patient count data. Emory and Morehouse School of Medicine researchers can now explore patient populations, confirm and demonstrate feasibility, and find potential partners for multi-site studies. | | | | Read More | | |
| |
| | | | Participant Recruitment: When an Investigator Recruits Himself for a Study (PDF) | | | | Read More | | |
| |
| | | | The Research Registry Toolkit is designed to support teams creating and managing research registries. Each section includes examples, best practices, and tools to guide conversations about research registry development and maintenance. | | | | Read More | | |
| |
| | | | Registration is now open for the SBIR Road Tour stopping at UGA in Athens, GA. National outreach effort connecting entrepreneurs working on advanced technologies to the country’s largest source of early stage funding – the SBIR/STTR programs. Opportunity for small businesses, innovators, researchers, entrepreneurs and technology companies to connect directly with SBIR/STTR program managers representing more than a dozen different federal agencies. SBIR/STTR programs provide over $3.7 billion in funding to small businesses each year in a wide variety of technology areas. | | | | Read More & Register | | |
| |
| |  | | The Georgia CTSA recently partnered with the All of Us Research Program. All of Us is a health research program funded by the National Institutes of Health (NIH). Its goal is to help researchers better understand why people get sick or stay healthy. The mission of the All of Us Research Program is simple: to speed up health research and medical breakthroughs. To do this, All of Us is asking one million people from across the U.S. to share their health ... | | | | Read More | | |
| |
| | | | Join us for a Science of Team Science Workshop from 9:00am – 10:30am via Zoom. Participate in this free interactive workshop to learn best practices for working as a scientific research team! | | | | Read More | | |
| |
| | | | Learn the pros and cons of different commercialization strategies to help determine the best fit for your technology. Our panel discussion format will allow you to ask questions and receive feedback to better understand complex go-to-market strategies. Registration link coming soon. Please note all talks for the remainder of this series will be hosted via webinar. | | | | Read More | | |
| |
| | | | Please join our Georgia CTSA Clinical Research Centers (GCRCs) staff for a very special 60th Anniversary Open House showcase on May 1st at the Emory University Hospital location, Unit HG-02. Tour and info sessions at 10:00am, 12:30pm, and 2:00pm. | | | | Read More | | |
| |
| | | | 2020 Statistical Methods in Imaging (SMI) Conference will be held at Emory Rollins School of Public Health (RSPH). The SMI conference is the annual meeting of the ASA Statistics in Imaging section. Please be aware that due to global concern over coronavirus, the dates of the conference are subject to change. | | | | Read More | | |
| |
| | | | Georgia CTSA is proud to announce it is a Silver Sponsor of this year's conference at the Georgia Aquarium! Registration is open now. Georgia CTSA Innovation Catalyst Director Wilbur Lam, MD, PhD, is this year's co-chair. CME is also offered. | | | | Read More | | |
| |
| For more information on Georgia Clinical & Translational Science Alliance (Georgia CTSA), please visit
www.GeorgiaCTSA.org. Do you have news, seminars, or events of interest to clinical and translational researchers? Send them to
GeorgiaCTSA@emory.edu by noon on Thursday. To suggest subscribers or unsubscribe to the listserv please email
GeorgiaCTSA@emory.edu.
Please include the following citation in any publications resulting from direct or indirect Georgia CTSA support, "Supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number UL1TR002378. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health." KL2 Scholars should also list KL2TR002381 and TL1 Trainees should also list TL1TR002382. |
| |
|
